Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".
View / Open Files
Publication Date
2018-05-29Journal Title
Circulation
ISSN
0009-7322
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
137
Issue
22
Pages
2413-2414
Language
eng
Type
Article
Physical Medium
Print
Metadata
Show full item recordCitation
Hadinnapola, C., Graf, S., & Morrell, N. (2018). Response by Hadinnapola et al to Letter Regarding Article, "Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension".. Circulation, 137 (22), 2413-2414. https://doi.org/10.1161/CIRCULATIONAHA.118.033970
Keywords
Humans, Hypertension, Pulmonary, Protein-Serine-Threonine Kinases, Cohort Studies, Mutation, Familial Primary Pulmonary Hypertension
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (BRC 2012-2017)
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Medical Research Council (MR/K020919/1)
British Heart Foundation (None)
Identifiers
External DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.033970
This record's URL: https://www.repository.cam.ac.uk/handle/1810/285689
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.